Current stock page

Catalysts

NVAX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

NVAXNovavax, Inc.

Healthcare / Biotechnology

$8.53−$0.23 (−2.68%)

Latest quote

  • Momentum
    77
  • Value
    —
  • Quality
    62
  • Risk resilience
    38
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 25, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ —

Momentum 77/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment -1.59%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 77/100AIQ Edge — —
Beat rate
88%
7 of 8 reported periods
Average surprise
+196.0%
Across covered historical reports
Latest result
+45.1%
Nov 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 5, 2026—-$0.35-$0.19+45.1%$50.42M$68.3M
Aug 6, 2026—-$0.38-$0.32+15.8%$52.51M$56.7M
May 6, 2026—-$0.25-$0.06+76.0%$79.81M$139.51M
Feb 26, 2026—-$0.66$0.11+116.7%$89.85M$147.14M
Nov 6, 2025—-$1.08-$1.25-15.7%$42.13M$70.45M
Aug 6, 2025—-$0.07$0.62+985.7%$152.61M$239.24M
May 8, 2025—$0.71$2.93+312.7%$343.85M$666.66M
Feb 27, 2025—-$0.75-$0.51+32.0%$84.38M$88.31M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
5
Buy
1
Hold
3
Sell
12-month analyst target
$8.00
-6.16% versus current price
Based on 9 analyst observations. Targets are estimates, not predictions.
Low target
$8.00
-6.16% vs latest price
Average target
$8.00
-6.16% vs latest price
High target
$8.00
-6.16% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 25, 2027

Next known earnings or reporting date.

EPS estimate$0.54

Current analyst expectation for the upcoming report.

Revenue estimate$216M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score77

Where event reaction would show up first.

AIQ score—

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
9
Average target
$8.00
Target upside
-6.16%
Target range
$8.00 - $8.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
2
Negative
1
zacks.com · Nov 10, 2026

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

seekingalpha.com · Nov 10, 2026

Novavax, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NVAX) 2026-11-10

2026-11-10. The following slide deck was published by Novavax, Inc.

seekingalpha.com · Nov 5, 2026

Novavax, Inc. (NVAX) Q3 2026 Earnings Call Transcript

Novavax, Inc. (NVAX) Q3 2026 Earnings Call November 5, 2026 8:30 AM ESTCompany ParticipantsNaina Zaman - Director of Investor RelationsJohn Jacobs -...

gurufocus.com · Oct 15, 2026

NVAX Maintained by Citigroup -- Price Target Raised to $8.00

Novavax (NVAX) Analyst Rating Update On October 15, 2026, Citigroup maintained a 'Sell' rating for Novavax (NVAX) while raising the price target from $7.00 t

Open full news and sentiment

NVAX Catalysts FAQ

What are the next catalysts for NVAX stock?

NVAX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move NVAX stock?

Upcoming events that could move NVAX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could NVAX's next earnings report affect the stock?

NVAX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive NVAX stock higher?

NVAX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt NVAX stock?

NVAX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.